View on Pubmed.gov 6245210 | View on doi.org 10.1021/jm00177...
A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
Abstract
References
Cited by 292 citations (total)
Journal Article Research Support, U.S. Gov't, P.H.S.
Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo.
Electronic publication date November 1, 1996
X H Chen [...] M W Adler et al.
We examined whether mu-antisense (AS) oligodeoxynucleotide (oligo) treatment can be used in a manner similar to the mu-selective irreversible antagonist...
Journal Article Research Support, N.I.H., Extramural
Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.
Electronic publication date December 14, 2010
N R Lenard [...] H-R Berthoud et al.
OBJECTIVE
To test the hypothesis that micro-opioid receptor signaling in the nucleus accumbens contributes to hedonic (over)eating and obesity. To investigate...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •